APA (7th ed.) Citation

Alzahrani, M., Turki, S. A., Rajban, W. A., Alshalati, F., Almodaihsh, F., Abuelgasim, K. A., . . . Mugairi, A. A. (2022, November). Pro106Leu MPL mutation is associated with thrombocytosis and a low risk of thrombosis, splenomegaly and marrow fibrosis. Platelets.

Chicago Style (17th ed.) Citation

Alzahrani, Musa, et al. "Pro106Leu MPL Mutation Is Associated with Thrombocytosis and a Low Risk of Thrombosis, Splenomegaly and Marrow Fibrosis." Platelets Nov. 2022.

MLA (9th ed.) Citation

Alzahrani, Musa, et al. "Pro106Leu MPL Mutation Is Associated with Thrombocytosis and a Low Risk of Thrombosis, Splenomegaly and Marrow Fibrosis." Platelets, Nov. 2022.